Abstract
No public abstract is available from the verified source records.
JACQUES THUILE, CHRISTIAN EVEN, Julien‐Daniel Guelfi
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
openalex
Confidence 95%
unpaywall
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up
10.1176/appi.ajp.160.7.1252 · 2003
Practice guidelines for the treatment of patients with bipolar disorder
2002
Efficacy and safety of venlafaxine in the treatment of bipolar II major depressive episode
10.1097/00004714-199810000-00010 · 1998
Venlafaxine monotherapy in women with bipolar II and unipolar major depression
10.1016/s0165-0327(99)00149-4 · 2000
Possible induction of mania and hypomania by olanzapine or risperidone: a critical review of reported cases
10.4088/jcp.v61n0910 · 2000
Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up
1994
Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSMIII): an Austrian double-blind, multicentre study
10.1192/s0007125000297535 · 1989
Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode
10.1016/s0165-0327(02)00407-x · 2004
Bipolar depression and antidepressant-induced mania: a naturalistic study
Confidence 95%
datacite
Confidence 0%
10.4088/jcp.v59n0706 · 1998
Mood-stabilisers reduce the risk of developing antidepressant-induced maniform states in acute treatment of bipolar I depressed patients
10.1016/s0165-0327(00)00172-5 · 2001
Spectrum of efficacy of lamotrigine in bipolar disorder: overview of double-blind placebo controlled studies
2000
A randomized, placebo controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder Divalproex maintenance study group
10.1001/archpsyc.57.5.481 · 2000
Depressive mania: response of residual depression to bupropion
10.1016/0006-3223(94)90050-7 · 1994
A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression Lamotrigine 602 Study Group
10.4088/jcp.v60n0203 · 1999
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder
10.4088/jcp.v64n0906 · 2003
Spectrum of efficacy of valproate in 55patients with rapid-cycling bipolar disorder
10.1176/ajp.147.4.431 · 1990
International Consensus Group on Bipolar I Depression Treatment Guidelines
10.4088/jcp.v65n0419 · 2004
Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patients
10.1097/00004714-199202001-00008 · 1992
A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder
10.1097/00004850-198910000-00006 · 1989
Valproate as an antidepressant in major depressive disorder
1996
Fluvoxamine and clomipramine in endogenous depression
10.1016/0165-0327(82)90009-x · 1982
Treatment of bipolar depression with carbamazepine: results of an open study
10.1016/s0006-3223(96)00339-3 · 1996
Bupropion as add-on strategy in difficult-to-treat bipolar depressive patients
10.1159/000049259 · 2002
The use of lithium in affective disorders I. Acute endogenous depression
10.1176/ajp.125.4.487 · 1968
Bupropion in the treatment of bipolar disorders: the same old story?
1992
A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders
10.1097/00004714-200012000-00004 · 2000
Long-term naturalistic treatment of depressive symptoms in bipolar illness with divalproatex Lithium in the setting of minimal antidepressant use
10.1016/s0165-0327(00)00279-2 · 2001
Antidepressants in bipolar disorder: the case for caution
10.1046/j.1399-5618.2003.00074.x · 2003
Antidepressants for bipolar depression: a systematic review of randomized, controlled trials
10.1176/appi.ajp.161.9.1537 · 2004
Unresolved referenced work
1990
Lithium response in unipolar versus bipolar depression
10.1176/ajp.129.1.44 · 1972
Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology
10.1177/0269881103017002003 · 2003
A double-blind study comparing idazoxan and bupropion in bipolar depressed patients
10.1016/s0165-0327(99)00041-5 · 1999
Venlafaxine-induced hypomanic switch in bipolar depression
10.1177/070674370104600815 · 2001
Maintenance efficacy of divalproex in the prevention of bipolar depression
10.1038/sj.npp.1300190 · 2003
Long-term use of valproate in primary psychiatric disorders
1989
Bupropion as a promising approach to rapid cycling bipolar II patients
1990
A double blind study of tranylcypromine treatment of major anergic depression
10.1097/00005053-198210000-00007 · 1982
Tranylcypromine versus imipramine in anergic bipolar depression
10.1176/ajp.148.7.910 · 1991
Bipolar depression: the real challenge
10.1016/j.euroneuro.2004.03.001 · 2004
Treatment of depression in bipolar disorder: new directions for research
10.1097/00004714-199312000-00005 · doi-reference
Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression
10.1176/ajp.157.1.124 · doi-reference
Risperidone added to mood stabilizers in mania: is there a difference in effect depending on mood stabilizer?
10.1016/s0924-977x(02)80202-4 · doi-reference
Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression
10.1016/s0165-0327(01)00434-7 · doi-reference
Double-blind comparison of lithium and imipramine in treatment of depression
10.1001/archpsyc.1975.01760230125010 · doi-reference
A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers
10.4088/jcp.v63n0607 · doi-reference
Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study
10.4088/jcp.v62n1011 · doi-reference
Role of risperidone in bipolar II: an open 6-month study
10.1016/s0165-0327(01)00435-9 · doi-reference
Bipolar depression: pharmacotherapy and related therapeutic strategies
10.1016/s0006-3223(00)00980-x · doi-reference
Treatment of imipramine-resistant recurrent depression IV. A double-blind crossover study of tranylcypromine for anergic bipolar depression
10.1176/ajp.149.2.195 · doi-reference
Tiagabine in treatment refractory bipolar disorder: a clinical case series
10.1034/j.1399-5618.2002.01201.x · doi-reference
Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder (2000)
10.4088/jcp.v63n0404 · doi-reference
Possible venlafaxine-induced mania
10.1097/00004714-199904000-00016 · doi-reference
Social and economic burden of mood disorders
10.1016/s0006-3223(03)00420-7 · doi-reference
Moclobemide vs imipramine in bipolar depression: a multicenter double blind clinical trial
10.1034/j.1600-0447.2001.00240.x · doi-reference
Venlafaxine-associated mania
10.1097/00004714-200104000-00019 · doi-reference
Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analysis of a double-blind, placebo-controlled, randomized clinical trial
10.1016/s0149-2918(04)90013-6 · doi-reference
Is divalproex sodium an appropriate initial treatment for bipolar depression?
10.3928/0048-5713-19960702-09 · doi-reference
Clozapine in a bipolar depressed patient
10.1176/ajp.150.6.986a · doi-reference
Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination
10.1001/archpsyc.1983.01790220086014 · doi-reference
The nature of bipolar depression: implications for the definition of melancholia
10.1016/s0165-0327(99)00144-5 · doi-reference
Which antidepressants flick the switch?
10.1046/j.1440-1614.2003.01207.x · doi-reference
Double-blind, placebo controlled comparison of imipramine and paroxetine in the treatment of bipolar depression
10.1176/appi.ajp.158.6.906 · doi-reference
Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants?
10.1007/s004060070035 · doi-reference
The clinical features of bipolar depression: a comparison with matched major depressive disorder patients
10.4088/jcp.v62n0314a · doi-reference
Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study
10.1034/j.1399-5618.2002.01189.x · doi-reference
A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression
10.4088/jcp.v65n0210 · doi-reference
Open-label adjunctive topiramate in the treatment of bipolar disorders
10.1016/s0006-3223(99)00316-9 · doi-reference
Clinical correlates of valproate augmentation in refractory bipolar disorders
10.3109/10401239309148921 · doi-reference
Metaanalysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine in the treatment of depression
10.1016/s0893-133x(98)00075-x · doi-reference
Citalopram as adjunctive therapy in bipolar depression
10.4088/jcp.v62n1212 · doi-reference
A controlled study of tetracyclic antidepressant – maprotiline (Ludiomil)
10.5694/j.1326-5377.1975.tb111845.x · doi-reference
Adjunctive tiagabine treatment of psychiatric disorders: three cases
10.3109/10401239809147036 · doi-reference
The long-term natural history of the weekly symptomatic status of bipolar I disorder
10.1001/archpsyc.59.6.530 · doi-reference